Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
Reports, Plans, Studies, Proceedings, Analysis, Visualizations, Peer Reviewed Articles, Books, Publications, Rules & Policy Guidance
WIPO _ Which are the most innovative economies in 2026?
United States of America
Government: U.S. States & Territories
Government: States (U.S.)
Illinois
Industry: Illinois

DMS Pharmaceutical Group Inc.

Attachments

*DLA: Contracts, Contractors & Awards
Architects: Medical Logistics, RTLS, Bioengineering & Biomedical Maintenance, Pharmacy, Pharmacy Benefits Management (PBM), Generics, Medication Adherence, Wholesalers & Supply Chain Managment, and Medication Therapy Management (MTM) Companies
Industry: Illinois

2024: DLA_DMS Pharmaceutical Group Inc.,** has been awarded an estimated $197,389,402 modification (P00021) extending the third two-year six-month option period of a two-year six-month base contract (SPE2DX-15-D-9000) with three two-year six-month option periods for prime vendor pharmaceutical and pharmaceutical-related products and support. This is a firm-fixed-price, requirements contract. Locations of performance are inside and outside the continental U.S., with a Nov. 12, 2025, performance completion date. Type of appropriation is fiscal 2025 through 2026 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania. (Awarded Oct. 8, 2024)
2025: DLA_AmerisourceBergen Drug Corp., (SPE2DX-25-D-1000 $5,649,602,820), DMS Pharmaceutical Group Inc., (SPE2DX-25-D-9000, $277,666,966), and Cardinal Health Inc., (SPE2DX-25-D-8000, $16,564,367), have each been awarded a firm-fixed-price requirements contract under solicitation SPE2DX-24-R-0001 for pharmaceutical and pharmaceutical-related products.
Parkridge, Illinois